Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MLH1 |
Variant | H264Lfs*2 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | MLH1 H264Lfs*2 indicates a shift in the reading frame starting at amino acid 264 and terminating 2 residues downstream causing a premature truncation of the 756 amino acid Mlh1 protein (UniProt.org). H264Lfs*2 results in aberrant splicing and deficient mismatch repair activity in an in vitro assay (PMID: 32849802), and therefore, is predicted to lead to a loss of Mlh1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
MLH1 mutant MLH1 inact mut MLH1 H264Lfs*2 |
Transcript | NM_000249.4 |
gDNA | chr3:g.37014544_37014545insTATA |
cDNA | c.790_790+1insTATA |
Protein | p.H264Lfs*2 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001354628.1 | chr3:g.37014544_37014545insTATA | c.790_790+1insTATA | p.H264Lfs*2 | RefSeq | GRCh38/hg38 |
NM_000249.3 | chr3:g.37014544_37014545insTATA | c.790_790+1insTATA | p.H264Lfs*2 | RefSeq | GRCh38/hg38 |
NM_001258271.1 | chr3:g.37014544_37014545insTATA | c.790_790+1insTATA | p.H264Lfs*2 | RefSeq | GRCh38/hg38 |
NM_001258271.2 | chr3:g.37014544_37014545insTATA | c.790_790+1insTATA | p.H264Lfs*2 | RefSeq | GRCh38/hg38 |
NM_000249.4 | chr3:g.37014544_37014545insTATA | c.790_790+1insTATA | p.H264Lfs*2 | RefSeq | GRCh38/hg38 |
NM_001354630.1 | chr3:g.37014544_37014545insTATA | c.790_790+1insTATA | p.H264Lfs*2 | RefSeq | GRCh38/hg38 |
NM_001354630.2 | chr3:g.37014544_37014545insTATA | c.790_790+1insTATA | p.H264Lfs*2 | RefSeq | GRCh38/hg38 |
NM_001354628.2 | chr3:g.37014544_37014545insTATA | c.790_790+1insTATA | p.H264Lfs*2 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|